Neuroone Medical Technologies (NMTC) Other Non Operating Income (2012 - 2026)
Neuroone Medical Technologies' (NMTC) quarterly Other Non Operating Income came in at $12279.0 in Q2 2026, down 83.72% on a YoY basis from $75432.0 in Q2 2025, and down 47.63% quarter-over-quarter from $23446.0 in Q1 2026.
Powered by 
Analysis
Neuroone Medical Technologies (NMTC) Other Non Operating Income (2012 - 2026) Analysis & Trends
Neuroone Medical Technologies (NMTC) has reported Other Non Operating Income for 11 consecutive years, with $12279.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non Operating Income fell 83.72% year-over-year to $12279.0; the trailing twelve-month figure through Jun 2026 stood at $148996.0 (up 18.14% YoY), and the FY2025 full-year result was $170492.0, up 36.2% from the prior year.
- Other Non Operating Income retreated to $12279.0 in Q2 2026 per NMTC's latest filing, from $23446.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $75432.0 in Q2 2025 and bottomed at -$26909.0 in Q1 2023.
- Historically, Other Non Operating Income has averaged $31588.8 across 5 years, with a median of $29623.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: Other Non Operating Income soared 396.14% in 2025, then sank 83.72% in 2026.
- Over 5 years, Other Non Operating Income stood at $51583.0 in 2022, then fell by 11.65% to $45575.0 in 2023, then sank by 79.36% to $9408.0 in 2024, then jumped by 396.14% to $46677.0 in 2025, then plunged by 73.69% to $12279.0 in 2026.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $12279.0, $23446.0, and $46677.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Neuroone Medical Technologies | 14.33 Mn | 12.29 Mn | 1.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,279.00 |
| Mar 31, 2026 | 23,446.00 |
| Dec 31, 2025 | 46,677.00 |
| Sep 30, 2025 | 66,594.00 |
| Jun 30, 2025 | 75,432.00 |
| Mar 31, 2025 | 19,058.00 |
| Dec 31, 2024 | 9,408.00 |
| Sep 30, 2024 | 22,220.00 |
| Jun 30, 2024 | 26,376.00 |
| Mar 31, 2024 | 31,008.00 |
| Dec 31, 2023 | 45,575.00 |
| Sep 30, 2023 | 29,623.00 |
| Jun 30, 2023 | 41,462.00 |
| Mar 31, 2023 | -26,909.00 |
| Dec 31, 2022 | 51,583.00 |
| Jun 30, 2020 | -2.02 Mn |
| Mar 31, 2019 | -553,447.00 |
| Jun 30, 2018 | -537,134.00 |
| Mar 31, 2018 | -537,134.00 |
| Dec 31, 2017 | -350,914.00 |